Table 6 OLS and linear probability estimates for underlying mechanisms of SEP-health gradients among Cuban aged 18–65: NSRFCD 2010 (with behavioural and risk perceptions)

1. SRH

Model 3

3.364*.

4.943*

−0.967

1.253

1.477

1.109

0.175

[1.340,5.387]

[2.945,6.941]

[−3.437,1.503]

[−1.939,4.445]

[−1.225,4.179]

[−0.189,2.406]

[− 1.651,2.002]

Model 4

3.525*

5.094*.

−0.156.

1.738

2.120

1.175

0.115

[1.399,5.652]

[3.151,7.036]

[−2.347,2.036]

[− 1.587,5.062]

[− 0.438,4.679]

[− 0.112,2.461]

[− 1.711,1.941]

Model 5

3.030

4.282*

− 0.253

1.194.

1.296.

1.169

0.250

[0.860,5.200]

[2.346,6.218]

[−2.366,1.859]

[−1.902,4.290]

[−1.395,3.988]

[− 0.044,2.383]

[− 1.529,2.029]

2. Hypertension

Model 3

0.034

0.027

0.008

0.025

0.023

0.005

0.059

[−0.013,0.080]

[−0.012,0.067]

[− 0.048,0.064]

[− 0.068,0.118]

[− 0.042,0.087]

[− 0.039,0.049]

[0.016,0.102]

Model 4

0.042

0.034

0.015

0.037

0.030

0.004

0.060

[−0.003,0.086]

[−0.004,0.073]

[− 0.048,0.078]

[− 0.058,0.132]

[− 0.039,0.099]

[− 0.041,0.049]

[0.017,0.104]

Model 5

0.036

0.030

0.016

0.029

0.021

0.006

0.059

[−0.013,0.086]

[−0.014,0.074]

[− 0.047,0.078]

[− 0.069,0.127]

[− 0.052,0.094]

[− 0.039,0.051]

[0.014,0.103]

3. General obesity

Model 3

−0.024

− 0.030

0.064

0.011

0.020

0.015

0.043

[−0.061,0.012]

[−0.062,0.002]

[0.017,0.110]

[−0.037,0.059]

[− 0.011,0.052]

[− 0.018,0.048]

[− 0.027,0.113]

Model 4

− 0.011

− 0.018

0.069

0.022

0.032

0.014

0.043

[−0.053,0.031]

[−0.058,0.021]

[0.019,0.118]

[−0.021,0.066]

[− 0.004,0.069]

[− 0.015,0.043]

[− 0.023,0.109]

Model 5

− 0.010

− 0.016

0.069*

0.016

0.024

0.017

0.046

[− 0.051,0.031]

[−0.051,0.019]

[0.020,0.117]

[−0.031,0.064]

[− 0.011,0.059]

[− 0.014,0.049]

[− 0.019,0.111]

4. Abdominal obesity

Model 3

−0.053

− 0.030

− 0.001

− 0.018

− 0.006

0.024

0.025

[− 0.121,0.016]

[−0.105,0.044]

[− 0.115,0.113]

[− 0.138,0.102]

[− 0.108,0.097]

[− 0.030,0.079]

[− 0.044,0.095]

Model 4

− 0.034

− 0.009

0.002

− 0.017

0.006

0.024

0.018

[−0.095,0.027]

[−0.078,0.060]

[− 0.116,0.120]

[− 0.123,0.089]

[− 0.092,0.103]

[− 0.028,0.076]

[− 0.055,0.092]

Model 5

− 0.048

− 0.031

− 0.002

− 0.021

− 0.008

0.032

0.029

[− 0.116,0.020]

[− 0.109,0.047]

[− 0.115,0.111]

[− 0.136,0.094]

[− 0.120,0.104]

[− 0.021,0.085]

[− 0.044,0.103]

5. High glucose

Model 3

− 0.022

− 0.020

0.056

0.034

0.037

−0.014

0.016

[−0.079,0.036]

[− 0.074,0.034]

[0.001,0.111]

[−0.025,0.092]

[− 0.008,0.083]

[− 0.045,0.016]

[− 0.026,0.058]

Model 4

− 0.022

− 0.022

0.065

0.038

0.045*

−0.009

0.007

[−0.080,0.035]

[−0.086,0.041]

[0.012,0.118]

[−0.013,0.090]

[0.014,0.075]

[−0.038,0.020]

[− 0.052,0.066]

Model 5

−0.020

− 0.020

0.064

0.040

0.045

−0.011

0.010

[−0.075,0.036]

[−0.068,0.029]

[0.008,0.121]

[−0.026,0.107]

[0.010,0.080]

[−0.039,0.018]

[− 0.046,0.067]

6. High cholesterol

Model 3

−0.013

−0.013

− 0.044

−0.036

− 0.033

− 0.063*

0.040

[−0.077,0.050]

[− 0.085,0.059]

[− 0.114,0.025]

[− 0.156,0.083]

[− 0.130,0.064]

[− 0.094,-0.031]

[− 0.081,0.161]

Model 4

− 0.007

− 0.021

− 0.050

− 0.036

− 0.052

− 0.065*

0.025

[−0.099,0.085]

[− 0.117,0.074]

[− 0.123,0.023]

[− 0.168,0.096]

[− 0.176,0.072]

[− 0.095,-0.035]

[− 0.082,0.132]

Model 5

− 0.014

− 0.030

− 0.066

− 0.048

− 0.049

− 0.062*

0.029

[− 0.084,0.056]

[− 0.116,0.056]

[− 0.153,0.021]

[− 0.182,0.085]

[− 0.171,0.072]

[− 0.092,-0.032]

[− 0.080,0.139]

7. High triglycerides

Model 3

0.023

− 0.023

0.047

− 0.025

0.008

− 0.023

− 0.071

[− 0.096,0.143]

[− 0.144,0.097]

[− 0.088,0.181]

[− 0.170,0.121]

[− 0.114,0.129]

[− 0.085,0.039]

[− 0.138,-0.003]

Model 4

− 0.009

− 0.058

0.028

−0.020

− 0.014

− 0.020

− 0.091

[−0.130,0.112]

[− 0.169,0.052]

[− 0.151,0.207]

[−0.191,0.152]

[− 0.167,0.140]

[− 0.081,0.042]

[−0.178,-0.004]

Model 5

0.001

−0.045

0.023

−0.020

0.007

−0.020

−0.084

[−0.107,0.109]

[−0.156,0.066]

[− 0.150,0.196]

[− 0.192,0.152]

[−0.146,0.160]

[− 0.078,0.037]

[− 0.153,-0.015]

8. Low HDL cholesterol

Model 3

0.079

0.164

−0.063

0.094

0.044

0.061

0.111

[−0.251,0.408]

[−0.226,0.554]

[− 0.167,0.041]

[− 0.212,0.400]

[−0.436,0.524]

[0.005,0.117]

[−0.024,0.246]

Model 4

0.120

0.218

−0.132

0.042

0.025

0.098

0.149

[−0.181,0.420]

[−0.168,0.604]

[− 0.437,0.172]

[− 0.766,0.850]

[−0.391,0.442]

[0.013,0.183]

[−0.190,0.487]

Model 5

0.155

0.272

−0.169

0.004

−0.067

0.097

0.088

[−0.453,0.763]

[−0.394,0.938]

[− 0.355,0.018]

[− 0.584,0.591]

[−0.438,0.304]

[− 0.042,0.236]

[− 0.137,0.314]

9. Metabolic syndrome

Model 3

0.001

0.019

0.080

−0.076

0.046

0.031

0.057

[−0.341,0.342]

[−0.334,0.371]

[− 0.209,0.368]

[− 0.446,0.294]

[−0.194,0.286]

[− 0.103,0.166]

[0.001,0.113]

Model 4

−0.023

−0.0002

0.080

0.002

0.069

0.012

0.030

[−0.231,0.184]

[−0.218,0.218]

[− 0.044,0.204]

[− 0.246,0.250]

[0.002,0.136]

[− 0.082,0.106]

[−0.097,0.158]

Model 5

0.002

0.038

0.041

−0.073

0.030

0.014

0.022

[−0.278,0.282]

[−0.244,0.321]

[− 0.162,0.245]

[− 0.502,0.357]

[−0.155,0.214]

[− 0.095,0.123]

[− 0.034,0.079]

10. One CVD risk factor

Model 3

−0.072

−0.043

− 0.072

0.070

− 0.031

0.064

0.008

[−0.396,0.253]

[−0.233,0.147]

[− 0.549,0.405]

[− 0.247,0.388]

[−0.550,0.488]

[0.017,0.112]

[−0.206,0.223]

Model 4

−0.048

0.050

−0.145

−0.033

− 0.038

0.040

− 0.088

[−0.228,0.133]

[− 0.026,0.125]

[− 0.787,0.497]

[−0.549,0.483]

[− 0.569,0.493]

[− 0.092,0.172]

[−0.161,-0.016]

Model 5

−0.061

0.007

−0.158

−0.048

− 0.070

0.061

− 0.098

[−0.500,0.379]

[− 0.356,0.370]

[− 0.518,0.201]

[−0.167,0.070]

[− 0.434,0.293]

[− 0.011,0.133]

[−0.152,-0.043]